Diabetes

Top Story

Ticagrelor monotherapy beneficial in complex PCI, diabetes: New TWILIGHT data

Ticagrelor monotherapy beneficial in complex PCI, diabetes: New TWILIGHT data
March 30, 2020

Read the Perspective from Claire Duvernoy, MD, FACC

In the Journals

In acute MI, care of homeless differs from general population

March 26, 2020
Researchers observed several significant differences regarding in-hospital care, CV risk profile and rehospitalization rates in patients with acute MI who were homeless…
FDA NewsPerspective

FDA rejects lower-dose empagliflozin 2.5 mg for type 1 diabetes

March 20, 2020
The FDA on Friday issued a complete response letter for a supplemental new drug application for a 2.5 mg dose of the SGLT2 inhibitor empagliflozin as an adjunct to…
Breaking NewsFDA News

FDA: Suspend SGLT2 inhibitors before surgery

March 17, 2020
The FDA on Tuesday approved safety labeling changes for all SGLT2 inhibitors, recommending temporary discontinuation of the medications before any scheduled surgery to…
More Headlines »